ACTIVE

Science at Work Staffing België

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
786,8 k €
-23.5% YoY
Revenue
5,0 M €
-18.8% YoY
Equity
4,7 M €
+19.9% YoY
Workforce
41,5 ETP
-15.1% YoY

What does Science at Work Staffing België do?

Science at Work Staffing België is a Private limited company incorporated in 2020. Its main activity is: Temporary employment agency activities. Its registered office is in Antwerpen. It employs on average 41,5 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0748.569.982
Incorporation
15/06/2020
Legal form
Private limited company
Registered office
Posthoflei 1 box 2
2600 Antwerpen · FlandreSee on map
Contributed capital
120 040,00 €
Latest accounts
31/12/2025
Average workforce
41,5 ETP
Activities (NACE)
78200Temporary employment agency activities· main78200Temporary employment agency activities78300Other human resources provision
Joint committees (2)
  • 200
  • 322
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20252024202320222021
Income statement
Revenue5,0 M €6,2 M €5,8 M €6,0 M €–
EBITDA940,7 k €1,3 M €1,2 M €1,7 M €1,8 M €
Operating result926,0 k €1,3 M €1,2 M €1,7 M €1,7 M €
Net result786,8 k €1,0 M €942,4 k €1,2 M €1,3 M €
Balance sheet
Equity4,7 M €3,9 M €2,9 M €2,0 M €1,4 M €
Total assets5,2 M €4,6 M €3,4 M €2,8 M €2,3 M €
Cash243,4 k €2,3 M €1,1 M €1,6 M €1,0 M €
Debts444,4 k €615,4 k €433,4 k €830,5 k €848,0 k €
Other
Workforce41,5 ETP48,9 ETP48,3 ETP53,8 ETP54,6 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 5 ended

Active mandates

IG Consult

Director · since 14 juin 2023 · 0747.746.274

Represented by Ilse Ghyselinck

Active
LOE

Director · since 14 juin 2023 · 0830.420.265

Represented by Thomas Eggermont

Active
PAUWELS MANAGEMENT

Director · since 14 juin 2023 · 0895.091.056

Represented by Bert Pauwels

Active

Ended mandates

EQUITY@WORK

Director · since 21 septembre 2022 · until 14 juin 2023 · 0884.443.030

Represented by Hans Swinnen

Ended
EQUITY@WORK

Director · since 21 septembre 2022 · 0884.443.030

Represented by Hans Swinnen

Ended
LOE

Director · since 21 septembre 2022 · 0830.420.265

Represented by Thomas Eggermont

Ended
PAUWELS MANAGEMENT

Director · since 21 septembre 2022 · 0895.091.056

Represented by Bert Pauwels

Ended
At this address

Other companies at this address

CompanyCBE no.
AgomAb Therapeutics● Active
0674.527.310
THE HOUSE OF DEVELOPMENT● Active
0547.666.948
Annual accounts

Full financial information

20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202212/06/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months19 months
Filing date29/06/202607/07/202520/06/202410/08/202330/06/2022
General meeting01/06/202602/06/202501/06/202401/06/202301/06/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202501/06/202629/06/2026DutchPDF
Abridged model31/12/202402/06/202507/07/2025DutchPDF
Abridged model31/12/202301/06/202420/06/2024DutchPDF
Abridged model31/12/202201/06/202310/08/2023DutchPDF
Abridged model31/12/202101/06/202230/06/2022DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 5 ended

Active mandates

IG Consult

Director · since 14 juin 2023 · 0747.746.274

Represented by Ilse Ghyselinck

Active
LOE

Director · since 14 juin 2023 · 0830.420.265

Represented by Thomas Eggermont

Active
PAUWELS MANAGEMENT

Director · since 14 juin 2023 · 0895.091.056

Represented by Bert Pauwels

Active

Ended mandates

EQUITY@WORK

Director · since 21 septembre 2022 · until 14 juin 2023 · 0884.443.030

Represented by Hans Swinnen

Ended
EQUITY@WORK

Director · since 21 septembre 2022 · 0884.443.030

Represented by Hans Swinnen

Ended
LOE

Director · since 21 septembre 2022 · 0830.420.265

Represented by Thomas Eggermont

Ended
PAUWELS MANAGEMENT

Director · since 21 septembre 2022 · 0895.091.056

Represented by Bert Pauwels

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates24/01/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates07/08/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other22/11/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares08/11/2022
    KAPITAAL - AANDELEN
    PDF
  • Mandates27/10/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office23/05/2022
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other17/06/2020
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025786,8 k €↓
  2. 2024
    Annual accounts 20241,0 M €↑
  3. 2023
    Annual accounts 2023942,4 k €↓
  4. 2022
    Annual accounts 20221,2 M €↓
  5. 2021
    Annual accounts 20211,3 M €
  6. 15/06/2020
    IncorporationPrivate limited company